Is Kratom Legal in California? CDPH Enforcement Explained

California never passed a kratom ban — and yet, as of 2026, you cannot lawfully buy kratom in a California store. The state built a comprehensive commercial prohibition out of existing food-and-drug law, agency enforcement, and licensing leverage, hitting 95 percent retailer compliance within months. Here is exactly how the CDPH action works, what it does and does not prohibit, and where the pending legislation could take things next.

The Mechanism: Adulteration, Not Scheduling

On October 24, 2025, the California Department of Public Health issued a statewide declaration that foods, dietary supplements, and drugs containing kratom or 7-OH are adulterated under the Sherman Food, Drug, and Cosmetic Act — California's state analog to federal food-and-drug law — and therefore illegal to manufacture or sell for consumption in California, at any age. The legal theory: because there is inadequate information providing reasonable assurance that the ingredients do not present a significant risk of illness or injury, and because they are not approved food additives or supplements, products containing them fail the Sherman Act's baseline standards. No legislature voted; no controlled-substance schedule changed. The CDPH invoked authority it already had, including statewide power to embargo, seize, and impound adulterated products.

The trigger was concrete: county health officials had linked highly concentrated and synthesized kratom derivatives — 7-OH products in particular — to six overdose deaths in Los Angeles County, on top of the FDA's escalating federal posture. CDPH's advisories describe the retail landscape bluntly: beverages, shots, powders, tablets, capsules, and gummies in bright packaging mimicking regulated products, marketed misleadingly as safer alternatives to opioids.

The Enforcement Campaign

The cross-agency design is what made it fast. CDPH supplied the legal theory and seizure authority; the Department of Alcoholic Beverage Control brought leverage over every alcohol-licensed convenience store and smoke shop — the exact retail channel where kratom products concentrated — and the tax authority (CDTFA) rounded out the coalition. A retailer weighing whether to keep a kratom shelf was really weighing its liquor license. The state had run the same playbook against illegal hemp products since October 2024, reaching 99 percent compliance, and applied it to kratom nearly unchanged.

What Is — and Isn't — Prohibited

• Prohibited: manufacturing or selling kratom or 7-OH products for human consumption anywhere in California, at any age, in any format.
• Not criminalized: personal possession. The CDPH action targets commerce under food-and-drug law; individuals holding kratom purchased elsewhere are not committing a state crime, though local ordinances vary.
• Local layers: San Diego, Oceanside, and Newport Beach enacted city bans even before the statewide action, and unincorporated Los Angeles County issued its own enforcement orders.
• Out-of-state shipments: the murkiest zone. Selling into California arguably violates the same adulteration rules, and compliant vendors treat California restrictively; several exclude at least the banned cities and counties, and enforcement attention on direct-to-consumer shipping is an open question.

Why the California Model Travels

The administrative route matters beyond California because most states have a Sherman Act equivalent — a state food-and-drug statute with adulteration standards and an agency empowered to enforce them. What California demonstrated is that a determined health department can build a commercial prohibition from that toolkit alone: no bill, no floor vote, no scheduling fight, and a timeline measured in months rather than sessions. The three-agency structure is the replicable part — pair the health department's legal theory with whatever licensing agency already has leverage over the retail channel (alcohol, tobacco, or lottery licensing all reach the same convenience-store universe) and compliance follows the licenses.

The model's limits are equally instructive. Administrative prohibition governs commerce, not possession, so it cannot reach personal conduct the way Tennessee's or Kansas's criminal statutes do. It is only as durable as the agency's determination and the governor behind it — a future administration could withdraw the interpretation without legislative action, just as one imposed it. And it is litigation-exposed in ways statutes are not: the Santee manufacturer suit will test the adulteration theory in court, and an adverse ruling would unwind the regime overnight. That fragility is precisely why AB 1088's statutory framework appeals even to some enforcement supporters — a testing-and-labeling law would survive administration changes that an enforcement posture might not.

AB 1088: The Regulated Alternative in Waiting

The policy fight is not over. Assembly Bill 1088 would replace the enforcement regime with a regulatory framework — age limits, product testing, and restrictions on 7-OH — administered by CDPH itself. It passed the Assembly and sits in the Senate Health Committee. California is one of the few big states with no Kratom Consumer Protection Act, and AB 1088 is effectively the KCPA question put to the nation's largest market: prohibition by adulteration doctrine, or regulation by statute. Advocates note the irony that CDPH's own enforcement success demonstrates the state could enforce a testing-and-labeling regime just as effectively as a ban.

Until that resolves, California functions as the largest commercial no-go zone in the country despite kratom never being scheduled there — a reminder that the legal map is written in more than one kind of law. The full national picture, including the DEA's parallel federal 7-OH action, is in our 2026 landscape guide and DEA scheduling explainer.